Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    The Value of axitinib in combination with Immuno-oncology (IO) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology China
    Innovative Digital Health Projects to increase the Quality of Life (QoL) of Multiple Myeloma (MM) patients
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Oncology Italy
    2024 RD Global Monitoring anti-TFPI RES
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Call for Independent Medical Education Grant Applications Oncology – Urothelial Carcinoma (UC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology All
    Health Services Research to Improve Management of mBC Patients Treated with Tucatinib
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Addressing Multiple Myeloma Gaps in Care for Patients in Latin America
    Release Date:
    Partner: International Myeloma Foundation
    Review Process: Expert Review Panel
    Education Oncology Argentina, Brazil, Colombia, Mexico
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Management of Atopic Dermatitis / Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    INNOVAtive Multi-disciplinary Clinical Management of INflammatory Diseases, 2023 IT INNOVA-MIND
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Italy
    Quality Improvement in Pediatric Endocrinology Fields
    Release Date:
    Partner: The Japanese Society for Pediatric Endocrinology
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease Japan
    Biomarker Testing / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Employment Support / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    2023 Oncology Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Translation: French (link)
    Fellowship Oncology Canada
    Approaches to Implement Bispecific Antibodies into Clinical Practice, Increase Awareness and Improve Delivery of Quality of Care
    Release Date:
    Partner: Myeloma Canada
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Improving Health Equity via Clinical Trial Capability Development in China
    Release Date:
    Review Process: Pfizer Internal
    Education Support for the Professions China
    Combination Therapy with Relugolix in the Treatment of Advanced Prostate Cancer
    Release Date:
    Partner: National Comprehensive Cancer Network; Myovant Sciences
    Review Process: Expert Review Panel
    Research Oncology USA
    Optimizing Women’s Health Conditions in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Internal Medicine Canada
    Women’s Health
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Internal Medicine Canada
    Accelerating Advancements in Women’s Health
    Release Date:
    Partner: Myovant Sciences
    Review Process: Expert Review Panel
    Research Internal Medicine USA
    Implementing Rapid Turnaround Time for NGS Molecular Testing for Cancer Patients in Non-Academic and Community Centres
    Release Date:
    Partner: Colorectal Cancer Canada and Thermo Fisher Scientific
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada